Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Hepatitis

Free Subscription 26.08.2019 1 Ann Intern Med 1 Arch Virol 1 Blood 1 BMC Cancer 1 BMC Gastroenterol 2 Eur J Gastroenterol Hepatol 1 Gut 2 Hepatology 2 J Hepatol 4 J Viral Hepat 2 PLoS One 1 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Intern Med

1. SIMON TG, Duberg AS, Aleman S, Hagstrom H, et al
   Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.
   Ann Intern Med. 2019 Aug 20. pii: 2748619. doi: 10.7326/M18-2753.
   PubMed     Text format     Abstract available
   
   

   
   Arch Virol

2. GAO M, Feng C, Ying R, Nie Y, et al
   A novel one-step quantitative reverse transcription PCR assay for selective amplification of hepatitis B virus pregenomic RNA from a mixture of HBV DNA and RNA in serum.
   Arch Virol. 2019 Aug 19. pii: 10.1007/s00705-019-04372.
   PubMed     Text format     Abstract available
   
   

   
   Blood

3. KUSUMOTO S, Arcaini L, Hong X, Jin J, et al
   Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy.
   Blood. 2018 Oct 19. pii: blood-2018-04-848044. doi: 10.1182/blood-2018-04-848044
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

4. PARK HK, Lee SS, Im CB, Im C, et al
   Hepatitis C virus genotype affects survival in patients with hepatocellular carcinoma.
   BMC Cancer. 2019;19:822.
   PubMed     Text format     Abstract available
   
   

   
   BMC Gastroenterol

5. MIDORIKAWA Y, Takayama T, Nakayama H, Higaki T, et al
   Prior hepatitis B virus infection as a co-factor of chronic hepatitis C patient survival after resection of hepatocellular carcinoma.
   BMC Gastroenterol. 2019;19:147.
   PubMed     Text format     Abstract available
   
   

   
   Eur J Gastroenterol Hepatol

6. CHEN J, Shi X, Luo T, Zhao Y, et al
   The correlations between hepatitis B virus infection and hepatocellular carcinoma with portal vein tumor thrombus or extrahepatic metastasis.
   Eur J Gastroenterol Hepatol. 2019 Aug 20. doi: 10.1097/MEG.0000000000001514.
   PubMed     Text format     Abstract available
   
   
7. DURCAN E, Hatemi I, Sonsuz A, Canbakan B, et al
   The effect of direct antiviral treatment on the depression, anxiety, fatigue and quality-of-life in chronic hepatitis C patients.
   Eur J Gastroenterol Hepatol. 2019 Aug 20. doi: 10.1097/MEG.0000000000001501.
   PubMed     Text format     Abstract available
   
   

   
   Gut

8. GILL US, Pallett LJ, Thomas N, Burton AR, et al
   Fine needle aspirates comprehensively sample intrahepatic immunity.
   Gut. 2018 Nov 28. pii: gutjnl-2018-317071. doi: 10.1136/gutjnl-2018-317071.
   PubMed     Text format     Abstract available
   
   

   
   Hepatology

9. JOHIRA Y, Hatooka H, Mori N, Fukuhara T, et al
   Regression of idiopathic thrombocytopenic purpura in a patient with eradication of hepatitis C virus by direct-acting antivirals.
   Hepatology. 2019 Aug 20. doi: 10.1002/hep.30900.
   PubMed     Text format     Abstract available
   
   
10. MCCULLOCH K, Romero N, MacLachlan J, Allard N, et al
    Modelling progress towards elimination of hepatitis B in Australia.
    Hepatology. 2019 Aug 16. doi: 10.1002/hep.30899.
    PubMed     Text format     Abstract available
    
    

    
    J Hepatol

11. ROSSI C, Jeong D, Wong S, McKee G, et al
    Sustained Virologic Response from Interferon-based Hepatitis C regimes IS associated with Reduced risk of Extrahepatic Manifestations.
    J Hepatol. 2019 Aug 6. pii: S0168-8278(19)30462.
    PubMed     Text format     Abstract available
    
    
12. DEGASPERI E, Spinetti A, Lombardi A, Landonio S, et al
    Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous daa failure.
    J Hepatol. 2019 Aug 6. pii: S0168-8278(19)30461.
    PubMed     Text format     Abstract available
    
    

    
    J Viral Hepat

13. JACKA B, Roy E, Hoj S, Minoyan N, et al
    Sexual behaviour as a risk factor for hepatitis C virus infection among people who inject drugs in Montreal, Canada.
    J Viral Hepat. 2019 Aug 21. doi: 10.1111/jvh.13194.
    PubMed     Text format     Abstract available
    
    
14. ROSA-HEZODE I, Chousterman M, Costes L, Labourdette C, et al
    Cascade of care for migrants tested Hepatitis C antibodies positive in France through a systematic screening program: the PRECAVIR study.
    J Viral Hepat. 2019 Aug 21. doi: 10.1111/jvh.13192.
    PubMed     Text format     Abstract available
    
    
15. TSAI MC, Lin CY, Hung CH, Lu SN, et al
    Evolution of Renal function under directly acting antivirals treatment for chronic hepatitis C: A real world experience.
    J Viral Hepat. 2019 Aug 21. doi: 10.1111/jvh.13193.
    PubMed     Text format     Abstract available
    
    
16. TO WP, Mak LY, Wong DK, Fung J, et al
    Hepatitis B core-related antigen levels after HBeAg seroconversion is associated with the development of hepatocellular carcinoma.
    J Viral Hepat. 2019 Aug 16. doi: 10.1111/jvh.13191.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

17. PUGA MAM, Bandeira LM, Pompilio MA, Rezende GR, et al
    Screening for HBV, HCV, HIV and syphilis infections among bacteriologically confirmed tuberculosis prisoners: An urgent action required.
    PLoS One. 2019;14:e0221265.
    PubMed     Text format     Abstract available
    
    
18. KWO PY, Puenpatom A, Zhang Z, Hui SL, et al
    Initial uptake, time to treatment, and real-world effectiveness of all-oral direct-acting antivirals for hepatitis C virus infection in the United States: A retrospective cohort analysis.
    PLoS One. 2019;14:e0218759.
    PubMed     Text format     Abstract available
    
    

    
    Vaccine

19. HYER RN, Janssen RS
    Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60-70years.
    Vaccine. 2019 Aug 17. pii: S0264-410X(19)31044.
    PubMed     Text format     Abstract available
    
    

    
    Virology

20. SHIOTA T, Li TC, Nishimura Y, Yoshizaki S, et al
    Integrin alpha3 is involved in non-enveloped hepatitis E virus infection.
    Virology. 2019;536:119-124.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: